Black Titan Corp

Black Titan Corp(BTTC)股票分析

$0.280

-0.001 (-0.36%)收盤時

Loading chart…
最高
0.309
開盤
0.285
成交量加權均價
0.29
成交量
92.11K
市值
—
最低
0.280
成交金額
26.67K
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

Black Titan Corporation is a holding company that operates through its subsidiaries, Titan Pharmaceuticals Inc. (TTNP), and TalenTec Sdn Bhd (TalenTec). TTNP is a pharmaceutical company that was previously developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura consists of a small, solid implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The resulting product is a solid matrix that is designed to be administered sub-dermally in a brief, outpatient procedure and is removed in a similar manner at the end of the treatment period. TalenTec is a provider of HCM software in Malaysia. It has introduced numerous human capital management (HCM) solutions to that market, such as Oracle PeopleSoft HCM, Oracle PeopleSoft Financials, Sunfish Workplaze HR, DayForce HCM, and MiHCM Cloud, through its holistic, integrated and reliable services.

AI 分析 of Black Titan Corp (BTTC)

賣出

Black Titan Corp is not a good buy right now due to its extremely low RSI of 22.133, indicating oversold conditions, and a staggering year-to-date change of -84.69%.

估值指標

Black Titan Corp(BTTC)目前預期本益比為 0.00,5 年平均預期本益比為 0.00。

預期本益比

嚴重低估
5 年均值 P/E
0.00
目前P/E
0.00
高估
0.00
低估
0.00

預期 EV/EBITDA

嚴重低估
5 年均值 EV/EBITDA
0.00
目前EV/EBITDA
0.00
高估
0.00
低估
0.00

預期股價營收比

嚴重低估
5 年均值 P/S
0.00
目前P/S
0.00
高估
0.00
低估
0.00

事件時間軸

2026-07-21 (ET)

09:30:00

Black Titan Announces Strategic Growth Initiatives to Expand Southeast Asia Market

2026-02-19 (ET)

10:40:00

Black Titan Corporation Signs Strategic MOU with PyratzLabs

2025-12-11 (ET)

09:40:00

Black Titan Releases Second Pillar of DAT+ Strategic Framework

08:50:00

Black Titan Introduces Digital Asset Strategic Framework DAT+

2025-11-12 (ET)

08:39:44

Black Titan names Lin as co-CEO

資訊

BTTC 常見問題 —— 由 Alphio AI 解答

Black Titan Corporation is a holding company that operates through its subsidiaries, Titan Pharmaceuticals Inc. (TTNP), and TalenTec Sdn Bhd (TalenTec). TTNP is a pharmaceutical company that was previously developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura consists of a small, solid implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The resulting product is a solid matrix that is designed to be administered sub-dermally in a brief, outpatient procedure and is removed in a similar manner at the end of the treatment period. TalenTec is a provider of HCM software in Malaysia. It has introduced numerous human capital management (HCM) solutions to that market, such as Oracle PeopleSoft HCM, Oracle PeopleSoft Financials, Sunfish Workplaze HR, DayForce HCM, and MiHCM Cloud, through its holistic, integrated and reliable services. It operates in the Financials sector.

Black Titan Corp is not a good buy right now due to its extremely low RSI of 22.133, indicating oversold conditions, and a staggering year-to-date change of -84.69%.

onyx_warden2026/9/27

# China and the U.S. Reach Consensus on $30 Billion in Tariff Reductions 🔥 Breaking: China and the U.S. have reached a consensus on $30 billion in tariff reductions. What does this mean for crypto? Core logic: Easing trade tensions reduce global geopolitical risk, which lifts risk appetite and is theoretically bullish for risk assets like BTC. ⚠️ But the key point: this tariff cut was already expected, so the positive news has likely been priced in ahead of time, making a sustained rally unlikely. What truly determines the broader direction of crypto is still Fed interest rates and U.S. crypto regulation policy. Tariffs are only a secondary catalyst. Question: In the short term, are you bullish on a rebound, or do you think the news is already priced in and could turn into a sell-the-news event? #CryptoNews #MacroMarket #btc70k

展開
註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易